Home › Phenylketonuria › Oregon › Portland
Phenylketonuria clinical trials in Portland, OR
5 studies for Phenylketonuria are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
RecruitingPhase 3
- Oregon Health and Science University, Portland
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
RecruitingPhase 4
- Oregon Health & Science University (OHSU) - PARENT, Portland
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
RecruitingPhase 3
- Oregon Health and Science University, Portland
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
RecruitingObservational study
- Oregon Health and Science University, Portland
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
RecruitingObservational study
- Oregon Health & Science University, Portland
About Phenylketonuria
In phenylketonuria (PKU), your body can't process phenylalanine, an amino acid in most foods. Read about genetics, screening, and special diets.
More about Phenylketonuria on MedlinePlus
Phenylketonuria trials in other cities
- Dallas, TX7 studies
- Pittsburgh, PA6 studies
- Indianapolis, IN6 studies
- Chicago, IL5 studies
- Salt Lake City, UT4 studies
- Atlanta, GA4 studies
- Boston, MA3 studies
- Tampa, FL3 studies
- Nashville, TN3 studies
- Aurora, CO3 studies
- Milwaukee, WI3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Prostate Cancer33 studies
- Breast Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.